The content on this site is intended for healthcare professionals only
Assessing cancer care value involves frameworks like the ESMO-MCBS scale, which helps measure treatment effectiveness through patient-centred and tumour-centred outcomes. Quality of life is increasingly important in clinical trials, influencing treatment choices.
The ESMO-MCBS scale also guides healthcare professionals in evaluating clinical trial benefits and impacts public policy for resource allocation.
Innovating cancer care access for low and middle-income countries
Addressing Breast Cancer Disparities in Africa
Empowering Women's Health: HPV screening and cervical cancer elimination in Pakistan
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
Multiple myeloma In Rwanda: The need for further research
Haemato-oncological Cancers
